2.36 USD
↘ 0.26 (9.92%)AT CLOSE (11:59 AM EDT)
Protalix BioTherapeutics, Inc. Common Stock (PLX) is currently trading at $2.36. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Buy" and "Buy" respectively. This is driven by a robust Altman Z-Score, exceptional Return on Equity (22.8%) and a bullish Golden Cross on the moving averages. Valuation metrics suggest PLX is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Aug 13, 2026.